دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Patients With Atrial FibrillationA Prespecified Subanalysis of the ELDERCARE–AF Randomized Clinical Trial
Masaru Kuroda, MD, PhD; Eiji Tamiya, MD, PhD; Takahisa Nose, MD, PhD; Akiyoshi Ogimoto, MD, PhD; Junki Taura, MS; Yuki Imamura, MS;Masayuki Fukuzawa, MS; Takuya Hayashi, MS; Masaharu Akao, MD, PhD; Takeshi Yamashita, MD, PhD; Gregory Y. H. Lip, MD; Ken Okumura, MD, PhD
doi : 10.1001/jamacardio.2022.0480
June 2022, Vol 7, No. 6, Pages 575-658
Effectiveness of a Text-Based Gamification Intervention to Improve Physical Activity Among Postpartum Individuals With Hypertensive Disorders of PregnancyA Randomized Clinical Trial
Jennifer Lewey, MD, MPH; Samantha Murphy, BA; Dazheng Zhang, MS; Mary E. Putt, PhD, ScD;Michal A. Elovitz, MD; Valerie Riis, MS; Mitesh S. Patel, MD, MBA; Lisa D. Levine, MD, MSCE
SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents
Øystein Karlstad, MScPharm, PhD; Petteri Hovi, MD, PhD; Anders Husby, MD, PhD; Tommi Härkänen, PhD; Randi Marie Selmer, MSc, PhD;Nicklas Pihlström, MSc; Jørgen Vinsløv Hansen, MSc, PhD; Hanna Nohynek, MD, PhD; Nina Gunnes, MSc, PhD; Anders Sundström, BA, PhD;Jan Wohlfahrt, MSc, DMSC; Tuomo A. Nieminen, MSocSc; Maria Grünewald, MSc, PhD; Hanne Løvdal Gulseth, MD, PhD; Anders Hviid, MSc, DMSC;Rickard Ljung, MD, PhD, MPH
Trends in 10-Year Outcomes Among Medicare Beneficiaries Who Survived an Acute Myocardial Infarction
Yun Wang, PhD1,2; Erica C. Leifheit, PhD3; Harlan M. Krumholz, MD, SM1,4,5
Sex and Race Differences in N-Terminal Pro–B-type Natriuretic Peptide Concentration and Absolute Risk of Heart Failure in the Community
Peder L. Myhre, MD, PhD; Brian Claggett, PhD; Bing Yu, PhD; Hicham Skali, MD, MSc; Scott D. Solomon, MD;Helge Røsjø, MD, PhD; Torbjørn Omland, MD, PhD, MPH; Kerri L. Wiggins, MS; Bruce M. Psaty, MD, PhD, MPH;James S. Floyd, MD; Elizabeth Selvin, PhD, MPH; Christie M. Ballantyne, MD; Amil M. Shah, MD, MPH
Long-term Survival After Out-of-Hospital Cardiac ArrestA Systematic Review and Meta-analysis
Simon A. Amacher, MD; Chantal Bohren, MBBS, BSc; René Blatter, MMed; Christoph Becker, MD;Katharina Beck, PhD; Jonas Mueller, MMed; Nina Loretz, MMed; Sebastian Gross, MSc; Kai Tisljar, MD;Raoul Sutter, MD; Christian Appenzeller-Herzog, PhD; Stephan Marsch, MD, PhD; Sabina Hunziker, MD, MPH
Association of Low-Dose Triple Combination Therapy vs Usual Care With Time at Target Blood PressureA Secondary Analysis of the TRIUMPH Randomized Clinical Trial
Sonali R. Gnanenthiran, MBBS, PhD; Nelson Wang, MD, MPhil; Gian Luca Di Tanna, PhD; Abdul Salam, PhD; Ruth Webster, PhD; H. Asita de Silva, DPhil;Rama Guggilla, MBBS, MMed; Stephen Jan, PhD; Pallab K. Maulik, PhD; Nitish Naik, MD; Vanessa Selak, PhD; Simon Thom, MD; Dorairaj Prabhakaran, MD;Aletta E. Schutte, PhD; Anushka Patel, PhD; Anthony Rodgers, PhD; for the TRIUMPH Study Group
Association of COVID-19 Vaccination With Risk of COVID-19 Infection, Hospitalization, and Death in Heart Transplant Recipients
Laura L. Peters, DNP, FNP; David S. Raymer, MD, MPHS; Jay D. Pal, MD, PhD; Amrut V. Ambardekar, MD
Current Landscape and Future Directions of Coronary Revascularization in Patients With Heart Failure
Yousif Ahmad, BMBS, PhD1; Alexandra J. Lansky, MD1; Eric J. Velazquez, MD1
Meaningful Evidence for Anticoagulation in the Gray (Elder) Zone
Karen P. Alexander, MD1
Treatment of Out-of-Hospital Cardiac Arrest
Jean Baptiste Lascarrou, MD, PhD1; Graham Nichol, MD, MPH2
A Child With Heart Failure and Bumpy Lesions on the Back
Balaji Arvind, DM1; Venkatakrishnan Ramakumar, DM1; Sivasubramanian Ramakrishnan, DM1
No Diagnostic Concerns With Cardiovascular Magnetic Resonance Imaging in Patients With Breast Cancer and Breast Implants
Charlotte Manisty, MBBS, PhD1,2; Ana Barac, MD, PhD3,4; Daniel Lenihan, MD5
No Diagnostic Concerns With Cardiovascular Magnetic Resonance Imaging in Patients With Breast Cancer and Breast Implants—Reply
Ohad Oren, MD1; Ron Blankstein, MD2; Deepak L. Bhatt, MD, MPH2
Could Neprilysin Be Already Inhibited by BNP in the LIFE Trial?
Nicolas Vodovar, PhD1; Alain Cohen-Solal, MD, PhD2; Damien Logeart, MD, PhD2
Could Neprilysin Be Already Inhibited by BNP in the LIFE Trial?—Reply
Douglas L. Mann, MD1; Adrian F. Hernandez, MD, MHS2,3; Eugene Braunwald, MD4
Communicating the Benefits of Vaccination in Light of Potential Risks
Ann Marie Navar, MD, PhD1,2; Robert O. Bonow, MD3,4
Who Is at Risk for Heart Failure?
Clyde W. Yancy, MD, MSc1,2; Sadiya S. Khan, MD, MSc1,3
